glp-1 and dual glp-1/gip receptor agonists Science Behind GLP 1 GIP Glucagon for Obesity Research | News & Announcements The Road towards Triple Agonists:

A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity

(2021) demonstrated that a single dose of EVOO produced greater postprandial GLP-1 concentrations than either refined olive oil or sunflower oil, and was associated with decreased ghrelin (the hunger hormone) in subjects including those with morbid obesity

Advancing basal insulin replacement in type 2 diabetes inadequately controlled with insulin glargine plus oral agents: a comparison of adding albiglutide, a weekly GLP-1 receptor agonist, versus thrice-daily prandial insulin lispro

Cell Metabolism , 27(4), 740756

This financial barrier can limit overall market growth and adoption rates

Physicians were asked about which condition they believe holds the most promise for future research and application of GLP-1RAs